Literature DB >> 6574471

Selective accumulation of cytosol CDP-choline as an isolated erythrocyte defect in chronic hemolysis.

D E Paglia, W N Valentine, M Nakatani, B J Rauth.   

Abstract

Erythrocytes from a young woman with chronic hemolytic anemia were found to contain 0.31-0.45 mM CDP-choline, concentrations that are 15-25 times those in normal erythrocytes and equivalent to 20-30% of the total adenine nucleotide content. Accumulation of CDP-choline has been reported only in erythrocytes from subjects with severe (homozygous) pyrimidine nucleotidase deficiency. In the latter syndrome, however, pyrimidine nucleotidase activity is very low and a spectrum of uridine- and cytidine-containing nucleotides is present along with epiphenomena involving glutathione and ribosephosphate pyrophosphokinase. By contrast, selective accumulation of CDP-choline was the only abnormality demonstrable in proband erythrocytes. Membrane phospholipids were quantitatively and qualitatively normal, compatible with the observation that mature erythrocytes maintain membrane phospholipids largely by passive exchange with plasma components or by acylation of lysophospholipids. Although the presence of small amounts of other CDP-containing cofactors, such as CDP-ethanolamine, could not be entirely excluded, the cytidine/choline ratio closely approximated 1:1 in all studies. These data are compatible with the view that choline phosphotransferase and ethanolamine phosphotransferase are separate enzymes in erythroid cells. Selective accumulation of CDP-choline in proband erythrocytes is also compatible with an inherited deficiency of choline phosphotransferase in erythroid precursors, though this hypothesis remains unproved.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6574471      PMCID: PMC393978          DOI: 10.1073/pnas.80.10.3081

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Characteristics of a pyrimidine-specific 5'-nucleotidase in human erythrocytes.

Authors:  D E Paglia; W N Valentine
Journal:  J Biol Chem       Date:  1975-10-25       Impact factor: 5.157

Review 2.  Hemolysis and changes in erythrocyte membrane lipids. I.

Authors:  S B Shohet
Journal:  N Engl J Med       Date:  1972-03-16       Impact factor: 91.245

3.  Hereditary hemolytic anemia with human erythrocyte pyrimidine 5'-nucleotidase deficiency.

Authors:  W N Valentine; K Fink; D E Paglia; S R Harris; W S Adams
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

4.  Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes.

Authors:  S Minakami; C Suzuki; T Saito; H Yoshikawa
Journal:  J Biochem       Date:  1965-12       Impact factor: 3.387

5.  Acetylcholine turnover estimation in brain by gas chromatography-mass spectrometry.

Authors:  D J Jenden; L Choi; R W Silverman; J A Steinborn; M Roch; R A Booth
Journal:  Life Sci       Date:  1974-01-01       Impact factor: 5.037

6.  An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers.

Authors:  J X Khym
Journal:  Clin Chem       Date:  1975-08       Impact factor: 8.327

7.  International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis.

Authors:  E Beutler; K G Blume; J C Kaplan; G W Löhr; B Ramot; W N Valentine
Journal:  Br J Haematol       Date:  1977-02       Impact factor: 6.998

Review 8.  Hereditary and acquired defects in the pyrimidine nucleotidase of human erythrocytes.

Authors:  D E Paglia; W N Valentine
Journal:  Curr Top Hematol       Date:  1980

9.  Distribution of erythrocyte nucleotides in pyrimidine 5'-nucleotidase deficiency.

Authors:  J D Torrance; D Whittaker
Journal:  Br J Haematol       Date:  1979-11       Impact factor: 6.998

10.  Erythrocyte choline concentrations are elevated in manic patients.

Authors:  R S Jope; D J Jenden; B E Ehrlich; J M Diamond; L F Gosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  2 in total

Review 1.  When to investigate for purine and pyrimidine disorders. Introduction and review of clinical and laboratory indications.

Authors:  H A Simmonds; J A Duley; L D Fairbanks; M B McBride
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 2.  When and how does one search for inborn errors of purine and pyrimidine metabolism?

Authors:  H A Simmonds
Journal:  Pharm World Sci       Date:  1994-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.